Fastpack Total Testosterone Immunoassay
Radioimmunoassay, Testosterones And Dihydrotestosterone. 510(k) K021972, from Qualigen, Inc. (Carlsbad, CA). Product code CDZ, class 1.
As of Nov 20, 2026, K021972 is an FDA 510(k) held by Qualigen, Inc., substantially equivalent on Aug 21, 2002 after 65 days, with 1 recall tied to it in FDA's recall database.
- Review time: 65 days
- Recalls: 1
- Cited as a predicate by: 1 device
The FastPack® Total Testosterone Immunoassay is a paramagnetic particle, chemiluminescence immunoassay for the in vitro quantitative determination of testosterone in human serum. The FastPack® Total Testosterone Immunoassay is designed for use with the FastPack® Analyzer System.
- Elecsys Testosterone AssayK964889 · Boehringer Mannheim Corp. · Mar 18, 1997
- Fastpack Testo ImmunoassayK101388 · Qualigen, Inc. · Feb 18, 2011
| Started | Recall | Status |
|---|---|---|
| Nov 8, 2013 | Z-0548-2014Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect. | Terminated |
- IDS-iSYS Total TestosteroneK252728 · Immunodiagnostic Systems Limited · Apr 15, 2026
- IDS-iSYS Free TestosteroneK240865 · Immunodiagnostic Systems Limited · Oct 23, 2024
- Access SHBGK233480 · Beckman Coulter, Inc. · Feb 8, 2024
- Access TestosteroneK223405 · Beckman Coulter, Inc. · Jan 13, 2023
- Elecsys Testosterone IIK211685 · Roche Diagnostics · May 6, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 17, 2002
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files